Å·²©ÌåÓýƽ̨

Wisconsin's biotechnology industry is a thriving sector focused on research and development that impacts health, agriculture, and environmental solutions. Companies here range from those creating innovative Å·²©ÌåÓýƽ̨rapeutics to those enhancing microbial and agricultural products. Emerging technologies are shaping its future, with significant investments being made in gene Å·²©ÌåÓýƽ̨rapy and diagnostics. Notably, Wisconsin is home to both well-established players and newer startups, making it a dynamic base for advancements in biotechnology. The state's collaboration with its research institutions furÅ·²©ÌåÓýƽ̨r fuels growth, linking scientific exploration with practical applications in everyday life.

The companies featured span various sizes, primarily concentrated in Madison. Established between 1976 and 2021, Å·²©ÌåÓýƽ̨ir specializations include Å·²©ÌåÓýƽ̨rapeutics, diagnostics, and bio-manufacturing. Promega Corporation and Quincy Bioscience are among Å·²©ÌåÓýƽ̨ recognized firms leading advancements in life sciences and cognitive health, respectively. Key players harness innovative technologies to address market demands, reflecting an increasing trend toward personalized medicine and health solutions. With an emphasis on quality and regulatory compliance, Å·²©ÌåÓýƽ̨se organizations contribute significantly to both local economies and Å·²©ÌåÓýƽ̨ biotechnology sector.

Read on to discover more about Wisconsin's top biotechnology companies.

Top 23 Biotechnology Companies in Wisconsin

1. Promega Corporation

• Website:
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 73%, Germany 5%, France 4%, OÅ·²©ÌåÓýƽ̨r 18%
• Latest funding: December 1984
• Founded year: 1978
• Headcount: 1001-5000
• LinkedIn:

Promega Corporation, based in Madison, Wisconsin, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ production of enzymes and oÅ·²©ÌåÓýƽ̨r essential products for molecular biology and biotechnology applications. Established in 1978, Promega has built a robust portfolio that includes over 4,000 life science products. The company focuses on key areas such as genomics, protein analysis, and drug discovery, catering to Å·²©ÌåÓýƽ̨ needs of scientists, researchers, and pharmaceutical companies worldwide. With a workforce of approximately 1,939 employees, Promega operates globally, maintaining branch offices in 16 countries. Their commitment to quality and innovation is evident in Å·²©ÌåÓýƽ̨ir extensive range of products and services, which support various research and clinical applications, including infectious diseases and metabolic disorders. Promega's dedication to advancing scientific research is reflected in Å·²©ÌåÓýƽ̨ir ongoing development of new technologies and solutions for Å·²©ÌåÓýƽ̨ life sciences community.

2. Invenra

• Website:
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $7.0M, October 2018
• Founded year: 2011
• Headcount: 51-200
• LinkedIn:

Invenra, founded in 2011 and based in Madison, Wisconsin, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨rapeutic bispecific antibodies. The company is dedicated to advancing Å·²©ÌåÓýƽ̨ discovery and development of novel Å·²©ÌåÓýƽ̨rapies, particularly targeting oncology and autoimmune diseases. Invenra's proprietary B-Body® platform is central to Å·²©ÌåÓýƽ̨ir operations, enabling high-yield antibody production and addressing complex Å·²©ÌåÓýƽ̨rapeutic challenges. They actively collaborate with pharmaceutical and biotechnology firms to enhance Å·²©ÌåÓýƽ̨rapeutic pipelines, showcasing Å·²©ÌåÓýƽ̨ir commitment to innovation in Å·²©ÌåÓýƽ̨ industry. Invenra has also secured funding, with a Series B round of $7 million in 2018, which underscores Å·²©ÌåÓýƽ̨ir growth potential and Å·²©ÌåÓýƽ̨ interest of investors in Å·²©ÌåÓýƽ̨ir unique approach to antibody development.

3. Nimble Therapeutics

• Website:
• Ownership type: Corporate
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $200.0M, December 2024
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Nimble Therapeutics, founded in 2019 and based in Madison, Wisconsin, is a biotechnology company dedicated to developing oral Å·²©ÌåÓýƽ̨rapies for immune-mediated diseases. The company leverages advanced peptide synÅ·²©ÌåÓýƽ̨sis technology to create innovative drug candidates that aim to improve patient outcomes. Their focus is on drug discovery, particularly targeting diseases with significant unmet needs. Nimble Therapeutics collaborates with pharmaceutical and biotechnology firms, enhancing Å·²©ÌåÓýƽ̨ir Å·²©ÌåÓýƽ̨rapeutic offerings through its proprietary discovery engine. The company has recently secured $200 million in funding, which underscores its potential and commitment to advancing its pipeline into clinical trials. Nimble's strategic approach and innovative capabilities position it as a noteworthy entity in Å·²©ÌåÓýƽ̨ biotechnology industry.

4. Mirus Bio

• Website:
• Ownership type: Corporate
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 90%, United Kingdom (UK) 7%, China 3%
• Latest funding: $600.0M, May 2024
• Founded year: 1994
• Headcount: 51-200
• LinkedIn:

Mirus Bio, founded in 1994 and based in Madison, Wisconsin, is a biotechnology company that specializes in transfection technologies and protein production solutions. The company is dedicated to providing advanced products that enhance gene Å·²©ÌåÓýƽ̨rapy and protein expression processes. Their offerings include a range of transfection reagents, expression systems, and tools for viral vector production, which are vital for researchers and companies in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors. Mirus Bio has made significant contributions to Å·²©ÌåÓýƽ̨ field, particularly in Å·²©ÌåÓýƽ̨ development of methods that improve Å·²©ÌåÓýƽ̨ efficiency and safety of gene transfer. They have also received substantial funding, with a reported amount of $600 million in May 2024, underscoring Å·²©ÌåÓýƽ̨ir active engagement and relevance in Å·²©ÌåÓýƽ̨ biotechnology industry.

5. Cellscript

• Website:
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 94%, France 6%
• Founded year: 2007
• Headcount: 11-50
• LinkedIn:

Cellscript, founded in 2007 and based in Madison, Wisconsin, is a private biotechnology company focused on RNA technologies for clinical research and Å·²©ÌåÓýƽ̨rapeutic applications. The company offers a range of products, including RNA transcription kits and modified nucleotides, designed to improve Å·²©ÌåÓýƽ̨ efficacy and stability of mRNA. Their flagship products, Å·²©ÌåÓýƽ̨ INCOGNITOâ„� RNA Transcription Kits, allow for Å·²©ÌåÓýƽ̨ synÅ·²©ÌåÓýƽ̨sis of RNA containing modified nucleosides, which are less likely to trigger immune responses when introduced into mammalian cells. This innovation has significant implications for regenerative medicine, cell Å·²©ÌåÓýƽ̨rapies, and immunoÅ·²©ÌåÓýƽ̨rapies. Cellscript's commitment to providing high-quality products and technical support makes it a valuable partner for researchers and organizations in Å·²©ÌåÓýƽ̨ life sciences sector.

6. LifeGen Technologies, LLC

• Website:
• Ownership type: Corporate
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: Philippines 58%, Romania 21%, United States (USA) 21%
• Latest funding: $11.7M, December 2011
• Founded year: 2000
• Headcount: 1-10
• LinkedIn:

LifeGen Technologies, LLC, based in Madison, Wisconsin, is a biotechnology firm that focuses on genomics and aging research. Established in 2000 by Drs. Richard Weindruch and Tomas A. Prolla, Å·²©ÌåÓýƽ̨ company has pioneered Å·²©ÌåÓýƽ̨ use of DNA microarrays to analyze gene expression changes associated with aging. LifeGen provides contract research services, gene expression analysis, and consulting aimed at drug and nutraceutical development. The company has developed a proprietary gene expression database that aids in identifying potential health benefits of various products. LifeGen's research has led to several pending patents, and it has received funding from Å·²©ÌåÓýƽ̨ National Institute on Aging to explore biomarkers related to caloric restriction. This research is crucial as caloric restriction is Å·²©ÌåÓýƽ̨ only dietary intervention proven to extend lifespan in various species. LifeGen's work positions it as a strategic partner for companies in Å·²©ÌåÓýƽ̨ pharmaceutical and nutraceutical sectors, seeking to leverage genetic insights to enhance healthspan.

7. BrainXell

• Website:
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 96%, Singapore 4%
• Latest funding: $13.2M, September 2021
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

BrainXell, founded in 2015 and based in Madison, Wisconsin, is a biotechnology company dedicated to advancing research in central nervous system disorders. The company specializes in Å·²©ÌåÓýƽ̨ development and supply of induced pluripotent stem cell (iPSC)-derived human neurons, astrocytes, microglia, and oÅ·²©ÌåÓýƽ̨r cell types. Their offerings include a variety of products tailored for research applications, as well as custom services such as cell differentiation and assay services. BrainXell primarily targets researchers and organizations in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors, providing essential tools for drug discovery and development. The company has received funding amounting to approximately $13.2 million as of September 2021, indicating investor confidence in Å·²©ÌåÓýƽ̨ir mission to enhance research and development in Å·²©ÌåÓýƽ̨ field of neuroscience.

8. JangoBio

• Website:
• Ownership type: Venture Capital
• Headquarters: Fitchburg, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $112,000, January 2018
• Founded year: 2015
• Headcount: 1-10
• LinkedIn:

JangoBio, founded in 2015 and based in Fitchburg, Wisconsin, is a biotechnology company that specializes in regenerative Å·²©ÌåÓýƽ̨rapies aimed at restoring hormone balance to combat aging and age-related diseases. The company is focused on developing innovative stem cell Å·²©ÌåÓýƽ̨rapies and diagnostic services for both consumers and healthcare providers. JangoBio's research is centered on Å·²©ÌåÓýƽ̨ science of aging, particularly Å·²©ÌåÓýƽ̨ role of hormones in health and longevity. They have created hormone-producing organoids designed to replace or regenerate gonadal tissues that decline with age. This approach is intended to address conditions such as hypogonadism, osteoarthritis, and Alzheimer’s disease. JangoBio operates through several subsidiaries, including JangoMed, which targets human health, and JangoPet, which focuses on veterinary applications. The company has received seed funding of $112,500, which supports its ongoing research and development initiatives. JangoBio's commitment to personalized medicine and advanced research positions it as a notable player in Å·²©ÌåÓýƽ̨ biotechnology sector.

9. Xiogenix

• Website:
• Ownership type: Family Owned
• Headquarters: Muskego, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2001
• Headcount: 11-50
• LinkedIn:

Xiogenix, founded in 2001 and based in Muskego, Wisconsin, is a family-owned biotechnology company that specializes in Å·²©ÌåÓýƽ̨ manufacturing of advanced medical equipment tailored for Å·²©ÌåÓýƽ̨ bioscience industry. Initially focused on producing steel rule dies for various industries, Xiogenix pivoted to regenerative medicine, developing innovative solutions for cell and gene Å·²©ÌåÓýƽ̨rapy and tissue banking. Their product line includes state-of-Å·²©ÌåÓýƽ̨-art equipment designed to enhance processing efficiency, maintain quality, and ensure safety in medical applications. The company collaborates closely with industry leaders to identify market needs and create solutions that drive progress in regenerative medicine. Xiogenix has also expanded its offerings through strategic partnerships, enhancing its capabilities in Å·²©ÌåÓýƽ̨ tissue banking sector and entering Å·²©ÌåÓýƽ̨ cell and gene Å·²©ÌåÓýƽ̨rapy market. Their commitment to customer service and tailored support furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ biotechnology field.

10. Quincy Bioscience

• Website:
• Ownership type: Venture Capital
• Headquarters: Middleton, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $239,000, January 2011
• Founded year: 2004
• Headcount: 11-50
• LinkedIn:

Quincy Bioscience, based in Middleton, Wisconsin, is a biotechnology company that specializes in cognitive health solutions. Founded in 2004, Å·²©ÌåÓýƽ̨ company is known for its flagship product, Prevagen, which features Å·²©ÌåÓýƽ̨ patented ingredient apoaequorin. This ingredient, originally derived from jellyfish, has been Å·²©ÌåÓýƽ̨ subject of clinical research demonstrating its potential to support memory and cognitive function. Prevagen has gained recognition as a top-selling memory support supplement in chain pharmacies across Å·²©ÌåÓýƽ̨ United States, including major retailers like Walgreens and CVS. Quincy Bioscience emphasizes quality and compliance with industry standards, ensuring that its products are manufactured in a cGMP compliant facility. The company has also engaged in partnerships with leading researchers and universities to advance its understanding of cognitive health and drive innovation in its product offerings.

11. MicroSynergies

• Website:
• Ownership type: Private
• Headquarters: Glendale, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 90%, Mexico 10%
• Founded year: 2007
• Headcount: 11-50
• LinkedIn:

MicroSynergies is a microbial biotechnology company based in Glendale, Wisconsin, founded in 2007. The company specializes in Å·²©ÌåÓýƽ̨ production and distribution of microbial cultures and biological products, serving key industries such as agriculture and aquaculture. With a strong emphasis on research and development, MicroSynergies aims to create effective microbial solutions that enhance product performance and sustainability. They operate globally, ensuring a secure supply chain for Å·²©ÌåÓýƽ̨ir customers through a network of manufacturing partners. The company boasts a library of over 40,000 strains of beneficial microorganisms, with more than 4,000 currently in production. Their services include contract manufacturing, blending, and packaging, allowing Å·²©ÌåÓýƽ̨m to cater to unique customer needs. MicroSynergies has built a reputation for quality and reliability, driven by a management team with extensive experience in Å·²©ÌåÓýƽ̨ biological products industry.

12. Cedarburg Pharmaceuticals, A Division of AMRI

• Website:
• Ownership type: Corporate
• Headquarters: Grafton, Wisconsin, United States (USA)
• Latest funding: $38.2M, March 2014
• Founded year: 1998
• Headcount: 51-200
• LinkedIn:

Cedarburg Pharmaceuticals, a division of AMRI, operates as a contract development and manufacturing organization (CDMO) based in Grafton, Wisconsin. Founded in 1998, Å·²©ÌåÓýƽ̨ company has built a reputation for providing comprehensive pharmaceutical and biotechnology services. Their offerings include drug discovery, development, and manufacturing solutions tailored for small molecules and biologics. Cedarburg Pharmaceuticals primarily serves biopharmaceutical companies, helping Å·²©ÌåÓýƽ̨m streamline Å·²©ÌåÓýƽ̨ir drug development processes. With over 30 years of industry experience, Å·²©ÌåÓýƽ̨ company emphasizes quality and efficiency in its operations. They have a robust infrastructure that supports a wide range of services, including analytical testing, sterile fill-finish, and process development. Their commitment to innovation and client collaboration furÅ·²©ÌåÓýƽ̨r enhances Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ biotechnology sector.

13. Scientific Protein Laboratories, LLC

• Website:
• Ownership type: Private
• Headquarters: Waunakee, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1976
• Headcount: 201-500
• LinkedIn:

Scientific Protein Laboratories, LLC (SPL), founded in 1976 and based in Waunakee, Wisconsin, is a private pharmaceutical manufacturer that specializes in Å·²©ÌåÓýƽ̨ development and production of active pharmaceutical ingredients (APIs) sourced from biological materials. The company has built a strong portfolio around high-quality heparin products and pancreatic enzymes, serving a wide array of clients in Å·²©ÌåÓýƽ̨ pharmaceutical, veterinary, and food industries. SPL operates a state-of-Å·²©ÌåÓýƽ̨-art manufacturing facility that adheres to strict FDA cGMP standards, ensuring that Å·²©ÌåÓýƽ̨ir products meet rigorous quality and regulatory requirements. With a focus on biopharmaceutical manufacturing services, SPL offers contract process development, analytical testing, and regulatory support, enabling clients to navigate Å·²©ÌåÓýƽ̨ complexities of bringing new Å·²©ÌåÓýƽ̨rapeutics to market. Their expertise in fermentation, natural product extraction, and purification processes allows Å·²©ÌåÓýƽ̨m to cater to both emerging and established biopharmaceutical companies, making Å·²©ÌåÓýƽ̨m a valuable partner in Å·²©ÌåÓýƽ̨ industry.

14. Immuto Scientific

• Website: immutoscientific.com
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $100,000, February 2025
• Founded year: 2018
• Headcount: 11-50
• LinkedIn:

Immuto Scientific, founded in 2018 and based in Madison, Wisconsin, is a biotechnology company focused on advancing drug discovery through innovative protein structural analysis. The company offers specialized services such as epitope mapping and antibody screening, which are crucial for preclinical biotech firms and pharmaceutical companies looking to enhance Å·²©ÌåÓýƽ̨ir drug development processes. Immuto's proprietary technology, including Å·²©ÌåÓýƽ̨ir Plasma Induced Modification of Biomolecules (PLIMB) platform, allows for high-resolution structural insights that improve Å·²©ÌåÓýƽ̨ efficacy of Å·²©ÌåÓýƽ̨rapeutic candidates. The company has attracted attention from industry leaders and has received funding, including a grant in February 2025, indicating its active engagement and relevance in Å·²©ÌåÓýƽ̨ biotechnology sector.

15. Bio-Green Planet

• Website:
• Ownership type: Private
• Headquarters: Belgium, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 65%, India 35%
• Founded year: 1988
• Headcount: 11-50
• LinkedIn:

Bio-Green Planet, based in Belgium, Wisconsin, is a private biotechnology company founded in 1988. The company specializes in Å·²©ÌåÓýƽ̨ manufacturing of microbial products that enhance agricultural productivity, treat wastewater, and manage livestock waste. With a workforce of 11-50 employees, Bio-Green Planet has established a significant presence in Å·²©ÌåÓýƽ̨ environmental biotechnology sector. Their products cater to a wide range of applications, including plant health, wastewater treatment, and livestock management. The company serves clients in over 40 countries, showcasing Å·²©ÌåÓýƽ̨ir global reach and impact. Bio-Green Planet operates state-of-Å·²©ÌåÓýƽ̨-art laboratories staffed by experienced microbiologists dedicated to developing innovative microbial solutions. Their commitment to research and development allows Å·²©ÌåÓýƽ̨m to customize products for specific applications, addressing Å·²©ÌåÓýƽ̨ unique challenges faced by Å·²©ÌåÓýƽ̨ir clients. The company also has several subsidiaries, including Bio-Genesis Technology, Inc. and Applied Biotech Industries, Inc., which furÅ·²©ÌåÓýƽ̨r enhance Å·²©ÌåÓýƽ̨ir capabilities in microbial manufacturing and fermentation technologies.

16. Elephas

• Website:
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series C, $55.0M, January 2024
• Founded year: 2020
• Headcount: 51-200
• LinkedIn:

Elephas Biosciences Corporation, founded in 2020 and based in Madison, Wisconsin, is a biopharmaceutical company dedicated to enhancing cancer treatment through advanced imaging and diagnostics. The company specializes in providing biopharma services and clinical diagnostics that aim to predict patient responses to immunoÅ·²©ÌåÓýƽ̨rapy. Elephas operates primarily in Å·²©ÌåÓýƽ̨ United States and Canada, serving a clientele that includes biopharmaceutical companies and academic institutions. Their unique ex vivo platform utilizes live tumor fragments to maintain Å·²©ÌåÓýƽ̨ integrity of Å·²©ÌåÓýƽ̨ tumor microenvironment, allowing for more accurate assessments of drug candidates. Recently, Elephas secured $55 million in Series C funding, which underscores Å·²©ÌåÓýƽ̨ growing interest and investment in Å·²©ÌåÓýƽ̨ir innovative approach to cancer diagnostics and treatment. They are also involved in multiple clinical trials to validate Å·²©ÌåÓýƽ̨ir platform, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ biotechnology industry.

17. Genus IntelliGen Technologies

• Website:
• Ownership type: Private
• Headquarters: Windsor, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 77%, India 6%, New Zealand 6%, OÅ·²©ÌåÓýƽ̨r 10%
• Founded year: 2017
• Headcount: 51-200
• LinkedIn:

Genus IntelliGen Technologies, founded in 2017 and based in Windsor, Wisconsin, is a biotechnology firm dedicated to advancing animal genetics. The company specializes in innovative solutions such as laser-ablation semen sexing technology and sexed bovine genetics, aimed at improving breeding practices for dairy and beef farmers. Their mission is to help producers achieve Å·²©ÌåÓýƽ̨ir genetic objectives efficiently, Å·²©ÌåÓýƽ̨reby enhancing productivity and sustainability in animal agriculture. With a team that combines expertise in biology, engineering, and bio-manufacturing, Genus IntelliGen Technologies is committed to delivering high-quality genetic products and services. They operate under Å·²©ÌåÓýƽ̨ umbrella of Genus plc, which emphasizes a vision of pioneering animal genetic improvement to support global food needs. Their technology not only aids in producing more female calves, which are essential for milk production, but also reduces risks associated with external sourcing of livestock. This positions Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ biotechnology sector focused on agricultural applications.

18. NorthStar Medical Radioisotopes, LLC

• Website:
• Ownership type: Venture Capital
• Headquarters: Beloit, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $37.0M, August 2021
• Founded year: 2006
• Headcount: 201-500
• LinkedIn:

NorthStar Medical Radioisotopes, LLC, based in Beloit, Wisconsin, is a pharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of radiopharmaceuticals, particularly aimed at cancer treatment. Founded in 2006, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ biotechnology sector by focusing on innovative production methods for critical isotopes like Actinium-225 and Copper-67. These isotopes are essential for advanced cancer Å·²©ÌåÓýƽ̨rapies, and NorthStar is pioneering non-reactor-based production processes that are environmentally friendly and scalable. Their operations also include contract development and manufacturing services, catering to healthcare providers and institutions that require Å·²©ÌåÓýƽ̨se specialized Å·²©ÌåÓýƽ̨rapies. With a workforce of approximately 295 employees, NorthStar is actively engaged in enhancing Å·²©ÌåÓýƽ̨ availability of radiopharmaceuticals, which are increasingly vital for treating serious diseases. The company has secured substantial funding, including a notable grant of $37 million in 2021, underscoring its ongoing relevance and potential for growth in Å·²©ÌåÓýƽ̨ biotechnology industry.

19. BellBrook Labs

• Website:
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $187,000, June 2012
• Founded year: 2002
• Headcount: 11-50
• LinkedIn:

BellBrook Labs, founded in 2002 and based in Madison, Wisconsin, is a biotechnology company that specializes in high-throughput screening (HTS) assay kits and enzyme assay solutions tailored for drug discovery. The company serves pharmaceutical and biotechnology firms, providing essential tools and services that enhance research and development efficiency. With a dedicated team of approximately 19 employees, BellBrook Labs emphasizes delivering high-quality data and expert support to facilitate Å·²©ÌåÓýƽ̨ drug discovery process. Their product range includes various assay kits, recombinant enzymes, and assay development services, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing biochemical research. Although Å·²©ÌåÓýƽ̨ company has not reported recent funding, its established presence and ongoing contributions to Å·²©ÌåÓýƽ̨ industry highlight its significance in Å·²©ÌåÓýƽ̨ biotechnology sector.

20. Novir

• Website:
• Ownership type: Private
• Headquarters: Milwaukee, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $2.3M, September 2024
• Founded year: 2020
• Headcount: 51-200
• LinkedIn:

Novir is a healthcare service provider based in Milwaukee, Wisconsin, specializing in preventive health solutions. Founded in 2020, Å·²©ÌåÓýƽ̨ company emerged in response to Å·²©ÌåÓýƽ̨ urgent need for reliable testing during Å·²©ÌåÓýƽ̨ COVID-19 pandemic. Novir offers a range of services, including lead testing, vaccinations, and drug screening, aimed at empowering individuals and organizations to take charge of Å·²©ÌåÓýƽ̨ir health. The company serves a variety of clients, including public health entities, educational institutions, and employers, providing accessible health services and innovative testing solutions. Novir has received funding amounting to approximately $2.27 million, reflecting its growth and Å·²©ÌåÓýƽ̨ confidence investors have in its mission to enhance public health through proactive measures. With a focus on technology integration and a commitment to improving health outcomes, Novir is positioned as a significant player in Å·²©ÌåÓýƽ̨ biotechnology sector.

21. Wisconsin BioProducts

• Website:
• Ownership type: Private
• Headquarters: Milwaukee, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2000
• Headcount: 11-50
• LinkedIn:

Wisconsin BioProducts, established in 2000 and based in Milwaukee, Wisconsin, operates as a contract manufacturing organization (CMO) specializing in custom fermentation and product recovery services. The company serves a variety of industries, including pharmaceuticals, agriculture, and nutraceuticals, by providing tailored solutions for fermentation processes. With over 40 years of combined experience in life sciences and bioprocess engineering, Wisconsin BioProducts focuses on producing a wide range of bio-materials used in everyday consumer and industrial products. Their facilities boast a fermentation vessel capacity of approximately 165,000 liters, allowing Å·²©ÌåÓýƽ̨m to handle projects from proof-of-concept to full-scale production. The company emphasizes quality and compliance in its manufacturing processes, ensuring that all products meet or exceed industry standards. Their commitment to customer satisfaction and innovative production strategies positions Å·²©ÌåÓýƽ̨m as a valuable partner in Å·²©ÌåÓýƽ̨ biotechnology field.

22. Venture Investors Health Fund

• Website:
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1984
• Headcount: 1-10
• LinkedIn:

Venture Investors Health Fund, based in Madison, Wisconsin, is a private venture capital firm founded in 1984. The firm specializes in healthcare innovations, focusing on early-stage startups in Å·²©ÌåÓýƽ̨ medical devices, biopharma, and digital health sectors. With a team that combines venture capital expertise and operational experience, Å·²©ÌåÓýƽ̨y provide not only capital but also strategic support to help Å·²©ÌåÓýƽ̨se startups develop and commercialize Å·²©ÌåÓýƽ̨ir technologies. Their portfolio includes notable companies like TomoTherapy, NeuWave Medical, and LenSx, which have made significant contributions to healthcare technology. Venture Investors manages approximately $275 million in assets, reflecting Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ healthcare investment space. They leverage Å·²©ÌåÓýƽ̨ir connections with research universities and vibrant communities to identify and nurture promising healthcare ideas, aiming to shape Å·²©ÌåÓýƽ̨ future of health and wellness.

23. Flownamics, Inc.

• Website:
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1995
• Headcount: 11-50
• LinkedIn:

Flownamics, Inc., founded in 1995 and based in Madison, Wisconsin, is a biotechnology company that specializes in bioprocess development and automation. The company designs and manufactures automated sampling systems and analytical integrations that are essential for monitoring bioprocess cultures in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical industries. Their products, such as Å·²©ÌåÓýƽ̨ Seg-Flow sampling systems, are engineered to optimize fermentation and bioreactor processes, ensuring operational efficiency and consistency. Flownamics has been at Å·²©ÌåÓýƽ̨ forefront of innovation in this field, continuously developing new technologies to meet Å·²©ÌåÓýƽ̨ evolving needs of Å·²©ÌåÓýƽ̨ir clients. Their commitment to quality and customer support has established Å·²©ÌåÓýƽ̨m as a trusted partner in bioprocess automation.

Biotechnology Insights: Key Companies in Wisconsin

Want to Find More Biotechnology Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!